Yeast, Unspecified

Dosage for Yeast, Unspecified varies significantly based on the intended use. For Allergenic Extracts used in immunotherapy, the dosage is highly individualized. It typically begins with a 'Build-up Phase' where a very dilute concentration (e.g., 0.05 mL of a 1:100,000 w/v dilution) is administered once or twice weekly. The dose is gradually increased over 3 to 6 months until a 'Maintenance Dose' is reached, which is often 0.5 mL of a 1:100 or 1:10 w/v concentration, administered every 2 to 4 weeks.

For Nutritional Supplementation (e.g., Brewer's Yeast), the standard adult dose is typically 1 to 2 tablespoons (15-30 grams) of powder daily, or 2 to 4 tablets (500 mg each) taken up to three times per day. Because 'Yeast, Unspecified' can contain varying levels of B-vitamins, patients should follow the specific labeling on the product provided by their pharmacist.

The use of Yeast, Unspecified in children must be supervised by a specialist.

• Allergy Testing/Immunotherapy: Pediatric dosing follows a similar escalating schedule to adults but may require more conservative increments. It is generally not recommended for children under the age of 5 due to the difficulty of monitoring for subjective symptoms of systemic reactions.
• Nutritional Use: Dosage for children is usually half the adult dose or based on weight (e.g., 100-200 mg/kg/day), but specific pediatric formulations should be used to avoid excessive intake of certain vitamins.

Renal Impairment

For nutritional forms of yeast, no specific dosage adjustments are usually required for mild to moderate renal impairment. However, in patients with end-stage renal disease (ESRD), the high phosphorus and potassium content of some yeast products must be considered. For allergenic extracts, renal function does not typically impact the local immune response, but caution is advised if the patient is on medications for kidney-related hypertension (like ACE inhibitors) that might complicate the management of an allergic reaction.

Hepatic Impairment

No dosage adjustment is generally necessary for hepatic impairment when using allergenic extracts. For nutritional supplements, patients with severe liver disease should be monitored if taking high doses of yeast-derived niacin, which can rarely be hepatotoxic in very high concentrations.

Elderly Patients

Elderly patients should start at the lower end of the dosing range. They are at a higher risk for adverse cardiovascular events if a systemic allergic reaction occurs during immunotherapy. Healthcare providers will often perform a more thorough cardiac screening before initiating treatment in patients over 65.

• Allergenic Extracts: These MUST be administered by a trained healthcare professional in a clinical setting equipped with emergency resuscitation equipment. You must remain in the office for at least 30 minutes after the injection to monitor for anaphylaxis.
• Oral Supplements: These can be taken with or without food. However, taking yeast supplements with a meal may reduce the likelihood of gastrointestinal upset or 'niacin flush.'
• Storage: Store liquid extracts in a refrigerator between 2°C and 8°C (36°F - 46°F). Do not freeze. Oral tablets should be kept in a cool, dry place away from direct sunlight.

• Immunotherapy: If you miss an appointment for an allergy shot, contact your allergist immediately. If the lapse is brief (a few days), the same dose may be given. If the lapse is long (weeks), the dose may need to be reduced to ensure safety.
• Supplements: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.

An overdose of Yeast, Unspecified allergenic extract can lead to Anaphylaxis, a life-threatening systemic reaction. Symptoms include difficulty breathing, swelling of the throat, rapid pulse, and a sharp drop in blood pressure. If an overdose is suspected during an injection, epinephrine must be administered immediately.

For oral supplements, an overdose may cause severe nausea, vomiting, diarrhea, or a profound 'niacin flush' (intense redness and itching of the skin). In case of accidental ingestion of large quantities, contact a Poison Control Center or seek emergency medical care.

> Important: Follow your healthcare provider's dosing instructions precisely. Do not adjust your dose or frequency without direct medical guidance, as this increases the risk of treatment failure or severe allergic reactions.

When using Yeast, Unspecified as an allergenic extract, the most common side effects are localized to the site of administration. These include:

• Local Swelling (Wheal): A raised, itchy bump at the injection site that typically appears within minutes and resolves within a few hours.
• Redness (Erythema): Warmth and redness surrounding the injection site.
• Itching (Pruritus): Intense itching at the site of skin testing or injection.

For oral nutritional forms, common side effects include:

• Gastrointestinal Distress: Mild bloating, flatulence (gas), or abdominal cramping as the gut microbiome adjusts to the yeast.
• Niacin Flush: A sensation of warmth, tingling, or redness on the face and neck, caused by the nicotinic acid content.

• Large Local Reactions: Swelling that exceeds 5-10 cm in diameter at the injection site, which may persist for 24-48 hours.
• Fatigue: Some patients report feeling unusually tired for several hours following an immunotherapy session.
• Headache: Mild to moderate tension-type headaches.
• Nausea: Occasional stomach upset following oral ingestion of concentrated yeast tablets.

• Systemic Urticaria: Hives appearing on parts of the body away from the injection site.
• Lymphadenopathy: Swelling of the lymph nodes near the site of injection.
• Joint Pain (Arthralgia): Transient joint discomfort reported in rare cases of high-dose immunotherapy.
• Migraine Exacerbation: In sensitive individuals, the tyramine content in certain yeast products may trigger migraines.

> Warning: Stop taking Yeast, Unspecified and call your doctor immediately or seek emergency services if you experience any of the following symptoms of Anaphylaxis:

1. 1Respiratory Distress: Wheezing, chest tightness, shortness of breath, or a persistent cough.
2. 2Upper Airway Obstruction: Swelling of the tongue, throat, or uvula; hoarseness; or difficulty swallowing.
3. 3Cardiovascular Collapse: Dizziness, fainting (syncope), rapid or weak pulse, or a sudden drop in blood pressure.
4. 4Generalized Skin Reactions: Rapidly spreading hives, intense itching over the entire body, or angioedema (deep tissue swelling, particularly around the eyes or lips).
5. 5Gastrointestinal Emergency: Severe abdominal cramps, vomiting, or diarrhea occurring immediately after an injection.

With prolonged use of Yeast, Unspecified immunotherapy, some patients may develop a persistent 'nodule' or small lump under the skin at the injection site. This is typically a granuloma and is benign, though it should be monitored. Long-term use of high-dose yeast supplements containing niacin may rarely lead to changes in liver function tests or glucose intolerance (elevated blood sugar). It is important to have periodic blood work if using high doses for extended periods.

While Yeast, Unspecified itself does not always carry a specific 'Black Box' label in the same way as high-risk pharmaceuticals, the FDA-approved labeling for allergenic extracts includes a prominent warning regarding the risk of Severe Systemic Reactions.

Summary of Warning: Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. Patients with unstable asthma are at increased risk. Extracts should only be administered by physicians who are exceptionally experienced in the treatment of allergic diseases and the management of systemic reactions. Patients must be observed for at least 30 minutes following administration. Epinephrine 1:1000 must be immediately available.

Report any unusual symptoms or persistent side effects to your healthcare provider to ensure your treatment plan remains safe and effective.

Yeast, Unspecified products, particularly those used for allergy diagnosis and treatment, carry significant risks if not used under strict medical supervision. The most critical safety point is the potential for an immediate, life-threatening allergic reaction. Patients must never self-administer allergenic extracts at home. Furthermore, patients should be in their 'baseline' state of health before receiving an injection; having a fever, active asthma flare, or severe respiratory infection can increase the risk of a dangerous reaction.

No specific FDA black box warning exists for the generic 'Yeast, Unspecified' entry, but all allergenic extracts derived from yeast are subject to the standard class warning for allergenic products. This warning emphasizes that these products can cause anaphylaxis and should only be used in facilities capable of handling such emergencies. If you have a history of severe reactions to any fungal or yeast product, you must disclose this to your physician before any testing begins.

• Allergic Reactions / Anaphylaxis Risk: This is the primary concern. Risk factors include high sensitivity levels, rapid dose escalation, and administration during peak allergy seasons.
• Asthma Status: Patients with poorly controlled or unstable asthma should not receive Yeast, Unspecified immunotherapy, as they are at the highest risk for fatal bronchospasm.
• Cardiovascular Health: Patients with underlying heart disease may not tolerate the physiological stress of a systemic reaction or the effects of epinephrine used to treat such a reaction.
• Autoimmune Disorders: Caution is advised in patients with active autoimmune diseases, as immunotherapy might theoretically exacerbate the condition by stimulating the immune system.
• Gout: Because yeast is high in purines, oral yeast supplements may increase uric acid levels, potentially triggering a gout attack in susceptible individuals.

• Post-Injection Observation: A mandatory 30-minute wait in the clinic after every dose of Yeast, Unspecified extract.
• Lung Function: For asthmatic patients, a peak flow meter or spirometry may be used before each injection to ensure airway stability.
• Liver Function Tests (LFTs): Recommended for patients taking high-dose oral yeast supplements for nutritional purposes to monitor for niacin-induced hepatotoxicity.
• Blood Glucose: Diabetics should monitor their blood sugar more closely when starting yeast supplements, as B-vitamins (specifically niacin) can affect insulin sensitivity.

Yeast, Unspecified does not typically cause sedation. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until they have fully recovered and been cleared by a medical professional.

Alcohol should be avoided immediately before and after receiving an injection of Yeast, Unspecified extract, as alcohol can increase blood flow to the skin and potentially accelerate the absorption of the allergen, increasing the risk of a reaction. For those taking oral supplements, alcohol may worsen the 'niacin flush.'

There is no 'withdrawal syndrome' associated with Yeast, Unspecified. However, stopping immunotherapy prematurely will result in the return of allergy symptoms. If you wish to stop treatment, discuss a tapering or transition plan with your allergist.

> Important: Discuss all your medical conditions, especially respiratory and heart problems, with your healthcare provider before starting any form of Yeast, Unspecified.

• Beta-Blockers (e.g., Propranolol, Metoprolol): These medications are contraindicated in patients receiving Yeast, Unspecified immunotherapy. The reason is not a direct interaction with the yeast, but rather that beta-blockers prevent epinephrine from working effectively. If the patient has an anaphylactic reaction to the yeast, the standard life-saving treatment (epinephrine) may fail, leading to a fatal outcome.
• Uncontrolled Asthma Medications: If a patient requires 'rescue' inhalers more than twice a week, they should not receive yeast extracts until their asthma is stabilized.

• ACE Inhibitors (e.g., Lisinopril): Similar to beta-blockers, ACE inhibitors may increase the severity of anaphylactic reactions and complicate the treatment of hypotension (low blood pressure) during a reaction.
• MAO Inhibitors (e.g., Phenelzine): Yeast products, especially aged or fermented ones, contain tyramine. In patients taking MAOIs, tyramine can cause a dangerous 'hypertensive crisis' (a sudden, severe increase in blood pressure).
• Tricyclic Antidepressants (TCAs): May potentiate the effect of epinephrine if it needs to be used to treat a reaction to the yeast extract.

• Antihistamines (e.g., Cetirizine, Loratadine): These drugs will suppress the 'wheal and flare' response during diagnostic skin testing, leading to false-negative results. They must be discontinued 3 to 7 days before testing.
• Immunosuppressants (e.g., Prednisone, Cyclosporine): These medications may reduce the effectiveness of yeast immunotherapy by dampening the immune system's ability to develop tolerance.
• Statins: When taken with yeast supplements high in niacin, there is a slightly increased risk of myopathy (muscle pain) or rhabdomyolysis.

• Fermented Foods: Consuming other yeast-heavy foods (aged cheeses, red wine) alongside yeast supplements may increase the total tyramine load, potentially causing headaches in sensitive individuals.
• High-Fat Meals: May delay the absorption of yeast-derived vitamins but do not typically cause clinical issues.

• St. John’s Wort: May interact with the metabolic pathways of some B-vitamins found in yeast, though clinical significance is low.
• Ginkgo Biloba: May have mild anti-platelet effects which, combined with the potential vascular effects of a systemic allergic reaction, could theoretically increase bleeding risk at injection sites.

• Skin Prick Tests: As mentioned, antihistamines and certain antidepressants will interfere with these results.
• Urine Glucose Tests: High doses of Vitamin C or B-vitamins found in yeast can occasionally cause false readings in certain older types of urine glucose tests.
• Urine Color: Riboflavin (Vitamin B2) in yeast will turn urine a bright, neon yellow; this is harmless but should be noted to avoid patient alarm.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter allergy medications, before starting Yeast, Unspecified.

Yeast, Unspecified must NEVER be used in the following circumstances:

1. 1Prior Severe Systemic Reaction: Any patient who has previously experienced life-threatening anaphylaxis to a yeast-derived product should not receive immunotherapy with that extract.
2. 2Uncontrolled or Severe Asthma: Patients with a Forced Expiratory Volume in 1 second (FEV1) of less than 70% of predicted value or those with frequent exacerbations are at an unacceptable risk for fatal airway obstruction during a reaction.
3. 3Beta-Blocker Therapy: Due to the inability to treat anaphylaxis effectively with epinephrine, this is considered an absolute contraindication in most clinical guidelines.
4. 4Acute Infection or Inflammation: Injections should be deferred if the patient has a high fever or acute respiratory infection to avoid confusing symptoms of the illness with a systemic reaction.

Conditions requiring a careful risk-benefit analysis by a specialist include:

• Pregnancy: While not strictly contraindicated if the patient is already on a stable maintenance dose, initiating new immunotherapy during pregnancy is generally avoided due to the risk of fetal hypoxia during a systemic reaction.
• Autoimmune Diseases: Conditions like Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis require caution as the immune stimulation of the extract might trigger a flare.
• Severe Atopic Dermatitis: May make skin testing results difficult to interpret.
• Malignancy: Patients with active cancer may have altered immune responses, making immunotherapy less predictable.

Patients allergic to Yeast, Unspecified may exhibit cross-sensitivity to other fungal elements. This includes:

• Molds: Such as Alternaria or Cladosporium.
• Mushrooms: In rare cases, ingestion of certain fungi may trigger symptoms in yeast-sensitive individuals.
• Antibiotics: While the 'Penicillin-class' EPC is listed, true cross-reactivity between yeast and penicillin is rare; however, patients should be monitored if they have a history of mold-derived antibiotic allergies.

> Important: Your healthcare provider will evaluate your complete medical history, including your current respiratory status and medication list, before prescribing or administering Yeast, Unspecified.

Pregnancy Category C: Animal reproduction studies have not been conducted with Yeast, Unspecified extracts. It is unknown whether these extracts can cause fetal harm when administered to a pregnant woman. The primary concern during pregnancy is not the direct effect of the yeast, but the potential for maternal anaphylaxis. A severe allergic reaction can lead to maternal hypotension and uterine hypoperfusion, resulting in fetal hypoxia (lack of oxygen to the baby).

• Clinical Practice: Most allergists will continue immunotherapy if the patient is already on a stable, well-tolerated maintenance dose. However, the dose is typically not increased during pregnancy. Initiating new therapy is generally discouraged until postpartum.

It is not known whether the allergenic proteins in Yeast, Unspecified extracts are excreted in human milk. However, most B-vitamins found in nutritional yeast are normal components of breast milk. Standard doses of nutritional yeast are generally considered safe during lactation. For immunotherapy, the risk to the nursing infant is considered negligible, but the mother should be monitored for systemic reactions as usual.

• Allergy Testing: Safe for use in children, though infants may have smaller skin reactions, making interpretation difficult.
• Immunotherapy: Generally reserved for children age 5 and older. Younger children may be unable to communicate the early, subjective symptoms of a systemic reaction (such as an 'itchy throat' or 'sense of doom').
• Nutritional Use: Yeast is a common food additive, but concentrated supplements should be dosed based on the child's age and nutritional needs as determined by a pediatrician.

Patients over the age of 65 may have a higher prevalence of comorbid conditions (like heart disease or COPD) that make them more vulnerable to the side effects of Yeast, Unspecified extracts.

• Pharmacokinetics: Reduced renal clearance in the elderly may lead to the accumulation of certain B-vitamins if taken in very high doses.
• Safety: The risk of a cardiovascular event during an allergic reaction is higher in this population. Healthcare providers may choose a more conservative dosing schedule.

In patients with significant kidney disease, the use of yeast as a nutritional supplement must be managed carefully. Yeast is high in phosphorus and potassium, which can accumulate in the blood (hyperphosphatemia and hyperkalemia) when kidney function is impaired. For allergenic extracts, no specific dose adjustment is needed, but monitoring for blood pressure stability is essential.

For most patients with liver disease, Yeast, Unspecified is safe. However, in cases of advanced cirrhosis, the liver's ability to process high doses of niacin (nicotinic acid) may be compromised. Monitoring for jaundice or elevated liver enzymes is recommended if high-dose oral supplements are used.

> Important: Special populations require individualized medical assessment. Always inform your specialist about pregnancy status or chronic organ disease before starting treatment.

Yeast, Unspecified functions through two primary pharmacological pathways:

1. 1Immunological Pathway: As an allergen, the proteins (antigens) in the yeast extract are captured by Antigen-Presenting Cells (APCs). In sensitized individuals, these antigens trigger the release of mediators from mast cells via IgE binding. During immunotherapy, the repeated exposure induces the production of Regulatory T-cells (Tregs), which secrete IL-10 and TGF-beta. These cytokines suppress the allergic Th2 response and promote the production of IgG4, which acts as a 'decoy' or 'blocking' antibody, neutralizing the allergen before it can reach the IgE on mast cells.
2. 2Metabolic Pathway: As a nutritional source, the yeast provides B-vitamins that act as essential coenzymes. For example, Pyridoxine (B6) is converted to pyridoxal phosphate, which is a cofactor for over 100 enzymes involved in amino acid metabolism, neurotransmitter synthesis (like serotonin and GABA), and hemoglobin formation.

• Allergenic Response: The onset of the 'wheal and flare' reaction is rapid, typically peaking at 15-20 minutes. The 'late-phase' allergic reaction can occur 4-8 hours later.
• Nutritional Response: The metabolic effects of yeast-derived vitamins are gradual. For instance, correcting a B12 deficiency may take several weeks of consistent supplementation to show improvement in hematological markers (like red blood cell size).

| Parameter | Value (Nutritional/Systemic) |

|---|---|

| Bioavailability | 60-90% (B-vitamins) |

| Protein Binding | Variable (Albumin for Niacin) |

| Half-life | 45 min (Niacin) to 6 days (B12 in liver) |

| Tmax | 1-2 hours (Oral) |

| Metabolism | Hepatic (Enzymatic phosphorylation) |

| Excretion | Renal (Primary) |

• Molecular Formula: N/A (Complex biological mixture)
• Composition: Contains proteins (18-45kDa range), glycoproteins, beta-glucans, mannans, and B-complex vitamins.
• Solubility: Aqueous extracts are soluble in water and saline; glycerinated forms are miscible with water.
• Structure: Yeast cells consist of a thick chitin/glucan cell wall surrounding a cytoplasm rich in ribosomes and metabolic enzymes.

Yeast, Unspecified is categorized as a Standardized/Non-Standardized Allergenic Extract. It is related to other fungal extracts like Candida albicans and Saccharomyces cerevisiae, but the 'Unspecified' label allows for broader clinical application when specific strain identification is not required for the diagnostic or therapeutic goal.